ERIC H DAVIS
Medical Practice in Morgantown, WV
License number
Pennsylvania MD052738L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Morgantown, WV 26508
Pennsylvania
Pennsylvania
Personal information
See more information about ERIC H DAVIS at radaris.comName
Address
Phone
4500 10Th Ave, Vienna, WV 26105
4551 Worth St, Philadelphia, PA 19124
43 Evans Dr, Quarryville, PA 17566
4456 Cow Creek Rd, Saint Marys, WV 26170
449 Miller Ave, Mechanicsburg, PA 17055
Professional information
Compositions Comprising Nebivolol
US Patent:
2009021, Aug 27, 2009
Filed:
Feb 6, 2009
Appl. No.:
12/366866
Inventors:
Eric Davis - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
Assignee:
Mylan Laboratories, Inc. - Morgantown WV
International Classification:
A61K 31/353, A61K 31/401, A61K 31/41
US Classification:
514381, 514456, 514412, 514423
Abstract:
Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
Compositions Comprising Nebivolol
US Patent:
7838552, Nov 23, 2010
Filed:
Nov 15, 2005
Appl. No.:
11/273992
Inventors:
Eric Davis - Morgantown WV, US
John P. O'Donnell - Morgantown WV, US
Peter Bruce Bottini - Morgantown WV, US
Andrew Shaw - Morgantown WV, US
R. Preston Mason - Manchester MA, US
John P. O'Donnell - Morgantown WV, US
Peter Bruce Bottini - Morgantown WV, US
Andrew Shaw - Morgantown WV, US
R. Preston Mason - Manchester MA, US
Assignee:
Forest Laboratories Holdings Limited
International Classification:
A61K 31/352, C07D 311/04
US Classification:
514456, 514 1, 514451
Abstract:
Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
Compositions Comprising Nebivolol
US Patent:
7803838, Sep 28, 2010
Filed:
May 31, 2005
Appl. No.:
11/141235
Inventors:
Eric Davis - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
Assignee:
Forest Laboratories Holdings Limited
International Classification:
A61K 31/352, C07D 311/04
US Classification:
514456, 514 1, 514451
Abstract:
Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
Compositions Comprising Nebivolol
US Patent:
2009022, Sep 10, 2009
Filed:
Feb 6, 2009
Appl. No.:
12/366931
Inventors:
Eric Davis - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
John O'Donnell - Morgantown WV, US
Peter Bottini - Morgantown WV, US
Assignee:
Mylan Laboratories, Inc. - Morgantown WV
International Classification:
A61K 31/41, A61P 9/00
US Classification:
514381
Abstract:
Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.